Скачайте изображение (превью) выбрав качество

320x180 480x360 640x480 1280x720

In this video interview from ESC's 2021 Heart Failure Congress, Dr Julio Nunez Villota (University of Valencia, Valencia, ES) discusses the findings of the Preserve-HR trial. This was a randomised single-center study that aimed to find the effect of beta-blocker withdrawal in patients with HFpEF and chronotropic incompetence.

Questions:

1. Could you briefly remind us of the trial's main aims, design and endpoints?
2. What were the key findings of the Preserve-HR Trial?
3. How should these findings impact practice? What are the next steps?

Editor: Jordan Rance

Filmed Remotely from Valencia, 2021.

Radcliffe Group is a specialist provider of Cardiovascular, Renal and Metabolic (CVRM) content, The Radcliffe Group offers physicians access to content through a variety of media formats stemming from industry-leading peer-reviewed research journals, video interviews, live events and online medical courses.

Чтобы скачать видео "ESC HF 2021: β-blockers Withdrawal in Patients With HFpEF & Chronotropic Incompetence" передвинте ползунок вправо